Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
255.43B | 252.15B | 139.96B | 87.89B | 385.36B | Gross Profit |
51.98B | 54.58B | 30.99B | 21.97B | 67.28B | EBIT |
7.27B | 11.41B | -7.69B | -27.08B | -1.61B | EBITDA |
7.68B | 11.62B | -4.85B | -26.89B | -2.01B | Net Income Common Stockholders |
7.54B | 11.79B | -5.78B | -28.48B | -7.45B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
85.28B | 17.65B | 13.58B | 12.76B | 17.34B | Total Assets |
132.08B | 138.67B | 102.34B | 62.82B | 90.63B | Total Debt |
329.00M | 420.00M | 60.00M | 58.00M | 79.00M | Net Debt |
-84.62B | -17.23B | -13.52B | -12.71B | -17.26B | Total Liabilities |
87.91B | 102.75B | 78.03B | 72.47B | 72.21B | Stockholders Equity |
44.12B | 35.88B | 24.28B | -9.69B | 18.36B |
Cash Flow | Free Cash Flow | |||
13.24B | 14.24B | -9.49B | -25.61B | -22.02B | Operating Cash Flow |
13.96B | 14.99B | -8.24B | -24.17B | -18.92B | Investing Cash Flow |
-99.00M | 29.00M | 76.00M | -301.00M | -3.07B | Financing Cash Flow |
-41.00M | -30.00M | 39.86B | -51.00M | -41.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥105.36B | 11.98 | 0.43% | 14.07% | -0.42% | ||
67 Neutral | ¥32.54B | 4.50 | ― | 3.76% | -15.66% | ||
67 Neutral | $75.82B | 12.14 | 2.70% | 7.65% | 6.79% | ||
64 Neutral | ¥121.56B | 12.86 | 19.01% | 0.69% | 24.42% | 147.88% | |
61 Neutral | $6.69B | 11.69 | 3.01% | 3.94% | 2.60% | -21.51% |